| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | Esperion Therapeutics Inc | 1,637,125 | 133,851,000 | 19.93% | ||
| 2 | ZELTIQ AESTHETICS INCORPORATED | 2,602,738 | 76,702,000 | 11.42% | ||
| 3 | CEMPRA INC | 2,193,060 | 75,354,000 | 11.22% | ||
| 4 | LOXO ONCOLOGY INC COM | 3,452,493 | 62,248,000 | 9.27% | ||
| 5 | CHIMERIX INC | 1,022,943 | 47,260,000 | 7.04% | ||
| 6 | T2 BIOSYSTEMS INC | 2,523,300 | 40,953,000 | 6.10% | ||
| 7 | VERSARTIS INC COM | 2,279,568 | 34,695,000 | 5.17% | ||
| 8 | ADMA BIOLOGICS, INC. | 3,608,171 | 33,412,000 | 4.98% | ||
| 9 | SORRENTO THERAPEUTICS INC COM NEW | 1,703,855 | 30,022,000 | 4.47% | ||
| 10 | Agile Therapeutics, Inc. | 2,983,797 | 25,631,000 | 3.82% | ||
| 11 | TRANSENTERIX INC | 8,335,819 | 25,007,000 | 3.72% | ||
| 12 | CATALENT INC | 715,673 | 20,991,000 | 3.13% | ||
| 13 | DERMIRA INC | 1,102,046 | 19,341,000 | 2.88% | ||
| 14 | PARATEK PHARMACEUTICALS INC | 682,680 | 17,593,000 | 2.62% | ||
| 15 | PERNIX THERAPEUTICS HLDGS IN | 2,010,000 | 11,899,000 | 1.77% | ||
| 16 | Intersect ENT Inc | 350,000 | 10,021,000 | 1.49% | ||
| 17 | LOMBARD MEDICAL INC | 886,363 | 3,900,000 | 0.58% | ||
| 18 | ROKA BIOSCIENCE INC | 1,029,693 | 2,677,000 | 0.40% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-15-001932, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
